AI Driven Efficiency Just–Evotec Biologics combines AI-driven in silico molecular optimization with continuous bioprocessing and J.POD facilities to reduce cost of goods and enable rapid ramp-up for complex biologics. This creates a compelling value proposition for pharma and biotech clients developing mAbs, bispecifics and biosimilars seeking scalable, cost-efficient production and agile timelines.

J Train Platform The launch of the J.Train continuous biomanufacturing platform opens a market-ready option for clients seeking flexible production capacity and improved supply resilience, with pilot to commercial capability and potential cross-sell to Evotec's evolving client base.

Complex Biologics Position as a specialized CDMO for complex biologics including monoclonal antibodies, bi- and multispecifics, and biosimilars, with integrated development and manufacturing workflows, cGMP readiness, and AI-augmented optimization to shorten development timelines.

Digital Manufacturing Edge Leverage digital capabilities and data tooling to offer enhanced process analytics, quality by design, and faster change control, enabling data-driven improvements and scalable operations for clients with high data requirements.

Strategic Partnerships Tap into Evotec's global network and leadership in AI and in silico platforms to accelerate co-development deals and cross-sell to large pharma and biotech customers, expanding market reach and deal velocity.